Article By:
PropThink
Monday, October 27, 2014 1:39 PM EDT
Pain Therapeutics and Durect announced on Monday morning that Pfizer will discontinue development of Remoxy (Extended-Release oxycodone) and will return all rights to Pain Therapeutics.
In this article: PFE, DRRX, PTIE